22-G-Procore Needle for the Diagnosis of SETs of the Upper GI Tract

Study ID
NCT01726010

Study type
Interventional

Study phase
Not Applicable

Study status
Unknown status

Trial Acronym

PRO-SET

Trial Summary

The goal of this prospective study is to evaluate the feasibility of the 22-G Core Biopsy Needle with reverse bevel (Procore TM) in biopsy sampling of subepithelial tumors of the upper gastrointestinal tract.

More informations

Trial Starting Date

Sep 30,2012

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit